Related Experiment Video
Updated: Apr 21, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
HPV Vaccine: How Far have We Achieved?
1Nowrosjee Wadia Maternity/Jagjivan Ram Railway Hospital, 257, Walkeshwar Road, 400 006 Mumbai, India.
Abstract:
Globally, cervical cancer is the second most common cancer, and in India, it is the most common cancer in women. Human Papilloma virus (HPV) is the main cause of it. Although there are several methods for preventing cervical cancer, primary prevention by vaccination is the most effective option. HPV vaccine is safe and effective. It is expensive and is not a replacement for periodic cervical screening procedures. In developing countries, the cost effectiveness of vaccine and that of effective screening program with broader coverage is questionable. Today, HPV vaccine with regular cervical cancer screening program is the best possible tool to prevent cervical cancer.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Vaccines
Vaccine Production
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

